Efficacy and safety of low-dose lenalidomide plus dexamethasone in patients with relapsed or refractory POEMS syndrome

Li J, Zhang W, Jiao L, et al.

Eur J Haematol · 2015

Grade Ccohortn=12

Key Findings

  • Overall hematologic response 77%, complete response 44%
  • Neurological response 67%
  • VEGF response 91%

Referenced in (1 disease)

ID: pmid-25401269DOI: 10.1111/ejh.12479PMID: 25401269